Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05320289 · ClinicalTrials.gov registry record · NA
Feasibility Study of the AblaCare System in Transvaginal Ablation of Ovarian Tissue Under ULTRAsound Visualization in Women With Infertility Due to Polycystic Ovary Syndrome
A NA study, sponsored by May Health.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05320289 is a NA study that has completed, run by May Health. The registered enrollment target is 5 participants.
The verdict
NCT05320289, a NA study, has completed, sponsored by May Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The objective of the study is to provide preliminary evidence for the safety and effectiveness of the AblaCare System in transvaginal ablation of ovarian tissue under ultrasound visualization in women with infertility due to polycystic ovary syndrome (PCOS) who have not responded to first-line ovulation induction treatment or are contraindicated for or decline such treatment.
Interventions
- DEVICE AblaCare System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-05-12 |
| Est. Completion | 2023-10-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05320289
The ClinicalTrials.gov registry entry for NCT05320289 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is May Health, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AblaCare System is the first listed.
NCT05320289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05320289 about?
NCT05320289 is a clinical study titled "Feasibility Study of the AblaCare System in Transvaginal Ablation of Ovarian Tissue Under ULTRAsound Visualization in Women With Infertility Due to Polycystic Ovary Syndrome". The objective of the study is to provide preliminary evidence for the safety and effectiveness of the AblaCare System in transvaginal ablation of ovarian tissue under ultrasound visualization in women with infertility due to polycystic ovary syndrome (PCOS) who have not responded to first-line ovula...
What is the current status of trial NCT05320289?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2022-05-12. Estimated completion is 2023-10-11.
What interventions are being tested in trial NCT05320289?
The interventions under investigation include: AblaCare System (DEVICE).
Who is sponsoring clinical trial NCT05320289?
This trial is sponsored by May Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.